TT
Travis Alvin Thompson
Chief Financial Officer

Travis Alvin Thompson insider trades: Bicycle Therapeutics (BCYC) stock sales

Chief Financial Officer, Bicycle Therapeutics Last trade Oct 5, 2026 17 Form 4 filings
$28K
Sold, last 12 months
4 sales
$0
Bought, last 12 months
0 buys
15
Open-market trades
since 2023
1
Company
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Travis reports to the SEC

Open-market buys and sales

15 trades reported on SEC Form 4, newest first

DateStockTypeValue
Oct 5, 2026BCYC↓ Sell$3K
Jul 6, 2026BCYC↓ Sell$4K
Apr 6, 2026BCYC↓ Sell$4K
Jan 5, 2026BCYC↓ Sell$16K
Oct 3, 2025BCYC↓ Sell$3K
Jul 3, 2025BCYC↓ Sell$2K
Apr 3, 2025BCYC↓ Sell$2K
Jan 6, 2025BCYC↓ Sell$67K
Nov 11, 2024BCYC↓ Sell$157K
Oct 3, 2024BCYC↓ Sell$3K
Jul 3, 2024BCYC↓ Sell$3K
Apr 3, 2024BCYC↓ Sell$4K
Jan 3, 2024BCYC↓ Sell$11K
Oct 3, 2023BCYC↓ Sell$1K
Jul 3, 2023BCYC↓ Sell$2K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other BCYC insiders

Open-market trades in the last 12 months

About Travis Alvin Thompson's insider trades

Travis Alvin Thompson is Chief Financial Officer at Bicycle Therapeutics (BCYC). Since Jul 3, 2023, Travis has reported no open-market purchases and 15 sales worth $283K on SEC Form 4. In the last 12 months: 4 sales ($28K).

Their filings also include grants and awards (5 filings), option exercises (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every BCYC insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.